Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 404

Similar articles for PubMed (Select 22172386)

1.

11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.

Li FM, Nie Q, Wang RM, Chang SM, Zhao WR, Zhu Q, Liang YK, Yang P, Zhang J, Jia HW, Fang HH.

Nucl Med Biol. 2012 Apr;39(3):437-42. doi: 10.1016/j.nucmedbio.2011.10.003. Epub 2011 Dec 14.

PMID:
22172386
2.

L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.

Grosu AL, Weber WA, Riedel E, Jeremic B, Nieder C, Franz M, Gumprecht H, Jaeger R, Schwaiger M, Molls M.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):64-74.

PMID:
16111573
3.

l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.

Mahasittiwat P, Mizoe JE, Hasegawa A, Ishikawa H, Yoshikawa K, Mizuno H, Yanagi T, Takagi R, Pattaranutaporn P, Tsujii H.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):515-22. Epub 2007 Sep 27.

PMID:
17900820
4.

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH.

Neuro Oncol. 2013 Aug;15(8):1058-67. doi: 10.1093/neuonc/not002. Epub 2013 Mar 3.

5.

Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.

Rieken S, Habermehl D, Giesel FL, Hoffmann C, Burger U, Rief H, Welzel T, Haberkorn U, Debus J, Combs SE.

Radiother Oncol. 2013 Dec;109(3):487-92. doi: 10.1016/j.radonc.2013.06.043. Epub 2013 Aug 13.

PMID:
23953407
6.

High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.

Kosztyla R, Chan EK, Hsu F, Wilson D, Ma R, Cheung A, Zhang S, Moiseenko V, Benard F, Nichol A.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1100-6. doi: 10.1016/j.ijrobp.2013.09.008. Epub 2013 Oct 22.

PMID:
24161427
7.

Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.

Grosu AL, Feldmann H, Dick S, Dzewas B, Nieder C, Gumprecht H, Frank A, Schwaiger M, Molls M, Weber WA.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):842-54.

PMID:
12377338
8.

18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.

Jacobs AH, Thomas A, Kracht LW, Li H, Dittmar C, Garlip G, Galldiks N, Klein JC, Sobesky J, Hilker R, Vollmar S, Herholz K, Wienhard K, Heiss WD.

J Nucl Med. 2005 Dec;46(12):1948-58.

9.

Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.

Matsuo M, Miwa K, Tanaka O, Shinoda J, Nishibori H, Tsuge Y, Yano H, Iwama T, Hayashi S, Hoshi H, Yamada J, Kanematsu M, Aoyama H.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):83-9. doi: 10.1016/j.ijrobp.2010.09.020. Epub 2010 Nov 20.

PMID:
21095072
10.

Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.

Invest Radiol. 2010 Dec;45(12):755-68. doi: 10.1097/RLI.0b013e3181ec9db0.

PMID:
20829706
11.

Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.

Borbély K, Nyáry I, Tóth M, Ericson K, Gulyás B.

J Neurol Sci. 2006 Jul 15;246(1-2):85-94. Epub 2006 Mar 6.

PMID:
16603193
12.

Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.

Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1176-82. doi: 10.3174/ajnr.A1008. Epub 2008 Apr 3.

13.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
14.

Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

Nuutinen J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E, Norrgård S, Kulmala J, Teräs M, Minn H.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52.

PMID:
10924970
15.

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.

Weber DC, Zilli T, Buchegger F, Casanova N, Haller G, Rouzaud M, Nouet P, Dipasquale G, Ratib O, Zaidi H, Vees H, Miralbell R.

Radiat Oncol. 2008 Dec 24;3:44. doi: 10.1186/1748-717X-3-44.

16.

An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.

Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N, Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1049-58. doi: 10.1016/j.ijrobp.2010.07.002. Epub 2011 May 11.

PMID:
21570201
17.

Prediction of pathology and survival by FDG PET in gliomas.

Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, Christian B, Ruppert J, Bernstein T, Kraus G, Mantil JC.

J Neurooncol. 2003 Sep;64(3):227-37.

PMID:
14558598
18.

Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.

Pirotte BJ, Levivier M, Goldman S, Massager N, Wikler D, Dewitte O, Bruneau M, Rorive S, David P, Brotchi J.

Neurosurgery. 2009 Mar;64(3):471-81; discussion 481. doi: 10.1227/01.NEU.0000338949.94496.85.

PMID:
19240609
19.

[Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy].

Chen YR, Li WX, Lin YR, Chen LH.

Ai Zheng. 2004 Oct;23(10):1210-2. Chinese.

PMID:
15473938
20.

Imaging of non- or very subtle contrast-enhancing malignant gliomas with [¹¹C]-methionine positron emission tomography.

Galldiks N, Kracht LW, Dunkl V, Ullrich RT, Vollmar S, Jacobs AH, Fink GR, Schroeter M.

Mol Imaging. 2011 Dec;10(6):453-9.

PMID:
22201536
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk